[HTML][HTML] Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients
A Nojiri, I Anan, S Morimoto, M Kawai, T Sakuma… - Journal of …, 2020 - Elsevier
Background Fabry disease is one of the causes of left ventricular hypertrophy (LVH) and can
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …
Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients
A Nojiri, I Anan, S Morimoto, M Kawai… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Fabry disease is one of the causes of left ventricular hypertrophy (LVH) and can
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …
[引用][C] Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients
A Nojiri, I Anan, S Morimoto, M Kawai, T Sakuma… - Journal of …, 2020 - cir.nii.ac.jp
Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
[PDF][PDF] Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients
A Nojiri, I Anan, S Morimoto, M Kawai… - Journal of …, 2020 - researchgate.net
Background: Fabry disease is one of the causes of left ventricular hypertrophy (LVH) and
can be treated with enzyme replacement therapy or pharmacological chaperone therapy …
can be treated with enzyme replacement therapy or pharmacological chaperone therapy …
[HTML][HTML] Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients
A Nojiri, I Anan, S Morimoto, M Kawai… - Journal of …, 2020 - journal-of-cardiology.com
Background Fabry disease is one of the causes of left ventricular hypertrophy (LVH) and can
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …
Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients.
A Nojiri, I Anan, S Morimoto, M Kawai… - Journal of …, 2019 - europepmc.org
BACKGROUND: Fabry disease is one of the causes of left ventricular hypertrophy (LVH) and
can be treated with enzyme replacement therapy or pharmacological chaperone therapy …
can be treated with enzyme replacement therapy or pharmacological chaperone therapy …